Related Experiment Videos
[Valvular surgical treatment concurrent with myocardial revascularization]
P de L Lavítola1, L A Dallan, F Tarasoutchi
1Instituto do Coração, Hospital das Clínicas, FMUSP.
Arquivos Brasileiros De Cardiologia
|December 1, 1992
Summary
Combined valve surgery and myocardial revascularization showed similar mortality to isolated procedures. Clinical improvement supports continuing these associated surgical treatments for better patient outcomes.
Area of Science:
- Cardiovascular Surgery
- Cardiac Surgery
- Thoracic Surgery
Context:
- Myocardial revascularization (coronary artery bypass grafting) is often performed with valve surgery.
- Coronary insufficiency is common in patients undergoing aortic or mitral valve surgery.
Purpose:
- To evaluate morbidity and mortality associated with combined valve surgery and myocardial revascularization.
- To compare outcomes of combined procedures with isolated valve surgery.
Summary:
- A study of 103 patients undergoing combined valve and myocardial revascularization revealed immediate postoperative mortality of 10.6% and late mortality of 3.89%.
- Complications included low cardiac output, arrhythmias, mediastinitis, infarction, hemorrhage, graft occlusion, and sepsis.
- Late follow-up showed functional capacity improvements in most patients, with few requiring repeat revascularization.
Impact:
- Combined valve and myocardial revascularization procedures demonstrate acceptable mortality rates.
- Clinical improvement in patients undergoing these combined procedures supports their continued use.
- This approach offers a viable option for patients with combined valve and coronary artery disease.